%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.What is Er Therapeutics Inc?
Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of natural resource properties, primarily gold.
PNGM · Verdict
Moderate reward · high risk
PNGM's standout is balance sheet; cash flow and volatility weigh on the picture.
Based on 88% data coverage
PNGM · Verdict
What’s working & what to watch
Strengths 1
- Balance sheet68/100
Current ratio 0.00
Watchouts 4
- Cash flow5/100
Weak vs peers
- Volatility5/100
Weak vs peers
- Profitability10/100
0% return on equity
- Growth41/100
Earnings +57.9% CAGR
Model-based scoring. For information only — not financial advice.
What is Er Therapeutics Inc?
Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of natural resource properties, primarily gold. It holds 216 claims covering an area of approximately 4350 acres in 3 properties in Nevada, including the Fish project in Esmeralda County, the CPG project in Mineral County, and the Golden Snow property in Eureka County. The company is listed on the OTCCE in USA, operating in the Basic Materials sector, with a market capitalisation of 5.83K.
Financial Highlights
Investment Breakdown
Analysis
Reward: Moderate (40)The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.